000 01588 a2200445 4500
005 20250513225750.0
264 0 _c20010614
008 200106s 0 0 eng d
022 _a0960-9822
024 7 _a10.1016/s0960-9822(00)00863-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeyn, M A
245 0 0 _aS-phase cyclins are required for a stable arrest at metaphase.
_h[electronic resource]
260 _bCurrent biology : CB
_c
300 _a1599-602 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Alkylating
_xpharmacology
650 0 4 _aCell Cycle Proteins
_xmetabolism
650 0 4 _aCell Nucleus
_xmetabolism
650 0 4 _aCheckpoint Kinase 2
650 0 4 _aChromosomal Proteins, Non-Histone
650 0 4 _aCyclin B
_xmetabolism
650 0 4 _aDNA Damage
650 0 4 _aFungal Proteins
_xmetabolism
650 0 4 _aGenes, Reporter
650 0 4 _aMetaphase
_xdrug effects
650 0 4 _aMethyl Methanesulfonate
_xpharmacology
650 0 4 _aMitosis
_xdrug effects
650 0 4 _aNuclear Proteins
650 0 4 _aPhosphoproteins
650 0 4 _aProtein Kinases
_xmetabolism
650 0 4 _aProtein Serine-Threonine Kinases
650 0 4 _aRecombinant Fusion Proteins
_xmetabolism
650 0 4 _aS Phase
_xdrug effects
650 0 4 _aSaccharomyces cerevisiae
_xgenetics
650 0 4 _aSaccharomyces cerevisiae Proteins
700 1 _aHolloway, S L
773 0 _tCurrent biology : CB
_gvol. 10
_gno. 24
_gp. 1599-602
856 4 0 _uhttps://doi.org/10.1016/s0960-9822(00)00863-0
_zAvailable from publisher's website
999 _c11077092
_d11077092